glycyl-arginyl-glycyl-aspartyl-serine has been researched along with cytochalasin d in 1 studies
Studies (glycyl-arginyl-glycyl-aspartyl-serine) | Trials (glycyl-arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-serine) | Studies (cytochalasin d) | Trials (cytochalasin d) | Recent Studies (post-2010) (cytochalasin d) |
---|---|---|---|---|---|
190 | 0 | 42 | 2,871 | 0 | 440 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chihara, K; Fujita, T; Gotoh, M; Ishikawa, H; Kamioka, H; Mikuni-Takagaki, Y; Miyauchi, A; Notoya, K; Sekiya, H; Takagi, Y; Takano-Yamamoto, T; Yoshimoto, Y | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and cytochalasin d
Article | Year |
---|---|
AlphaVbeta3 integrin ligands enhance volume-sensitive calcium influx in mechanically stretched osteocytes.
Topics: Animals; Calcium; Cell Adhesion; Cell Size; Cells, Cultured; Cytochalasin D; Fluorescent Antibody Technique; Humans; Integrin alphaVbeta3; Ligands; Oligopeptides; Osteocytes; Osteopontin; Rats; Signal Transduction; Stress, Mechanical; Substrate Specificity | 2006 |